364 related articles for article (PubMed ID: 19413638)
1. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
[TBL] [Abstract][Full Text] [Related]
2. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
3. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
[TBL] [Abstract][Full Text] [Related]
4. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic neoductules].
Fischer HP; Meybehm M; Zhou H; Schoch J
Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
[TBL] [Abstract][Full Text] [Related]
6. [Epithelial-mesenchymal transition of biliary epithelial cells in advanced liver fibrosis].
Schulze F; Schardt K; Wedemeyer I; Konze E; Wendland K; Dirsch O; Töx U; Dienes HP; Odenthal M
Verh Dtsch Ges Pathol; 2007; 91():250-6. PubMed ID: 18314622
[TBL] [Abstract][Full Text] [Related]
7. Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells.
Schmitt-Graeff A; Jing R; Nitschke R; Desmoulière A; Skalli O
Hum Pathol; 2006 Sep; 37(9):1200-10. PubMed ID: 16938526
[TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
9. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
[TBL] [Abstract][Full Text] [Related]
10. Hepatoma in familial cholestatic cirrhosis of childhood: its occurrence in twin brothers.
Dahms BB
Arch Pathol Lab Med; 1979 Jan; 103(1):30-3. PubMed ID: 215101
[TBL] [Abstract][Full Text] [Related]
11. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
Riener MO; Fritzsche FR; Soll C; Pestalozzi BC; Probst-Hensch N; Clavien PA; Jochum W; Soltermann A; Moch H; Kristiansen G
Histopathology; 2010 Apr; 56(5):600-6. PubMed ID: 20459570
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma.
Suzuki T; Hoshi N; Watanabe K; Kasukawa R; Suzuki T
Fukushima J Med Sci; 1998 Dec; 44(2):93-105. PubMed ID: 10091381
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts.
Tanaka A; Tsuneyama K; Mikami M; Uegaki S; Aiso M; Takikawa H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1993-2000. PubMed ID: 17914982
[TBL] [Abstract][Full Text] [Related]
16. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
[TBL] [Abstract][Full Text] [Related]
17. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
18. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
Thasler WE; Schlott T; Thelen P; Hellerbrand C; Bataille F; Lichtenauer M; Schlitt HJ; Jauch KW; Weiss TS
Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324
[TBL] [Abstract][Full Text] [Related]
19. Survivin gene expression in chronic liver disease and hepatocellular carcinoma.
Montorsi M; Maggioni M; Falleni M; Pellegrini C; Donadon M; Torzilli G; Santambrogio R; Spinelli A; Coggi G; Bosari S
Hepatogastroenterology; 2007; 54(79):2040-4. PubMed ID: 18251156
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]